Literature DB >> 1617859

Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.

D F Kisor1, S M Watling, B J Zarowitz, R W Jelliffe.   

Abstract

A new nonparametric expectation maximisation (NPEM) algorithm for the estimation of population pharmacokinetic parameter values was evaluated. The algorithm, in the form of a personal computer program, was used to compute population pharmacokinetic parameter densities of gentamicin in a group of 9 patients with indicators of malnutrition. The 1-compartment parameter values for clearance (CL), volume of distribution (Vd) and elimination rate constant (k) were compared with values generated using a standard 2-stage (STS) approach. NPEM was used with a full data set (72 gentamicin concentrations) and a sparse data set (only peak and trough concentrations for each patient; 18 in total). There were no differences in parameter value estimations between the STS and NPEM with all the data (p greater than 0.05) or with the sparse data (p greater than 0.05). Mean parameter value estimates from the STS and NPEM (with sparse data) were used as a priori data sets in the USC*PACK gentamicin Bayesian program to predict concentrations in 8 subsequent patients with similar indicators of malnutrition. There were no differences in predicted gentamicin concentrations between STS (3.75 +/- 2.06 mg/L) and NPEM (3.75 +/- 2.17 mg/L). NPEM was able to generate population pharmacokinetic parameter values for gentamicin in a defined population of patients using sparse routine clinical data. It was also shown to function with only a single data point per patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617859     DOI: 10.2165/00003088-199223010-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  16 in total

Review 1.  Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies.

Authors:  R W Jelliffe; T Iglesias; A K Hurst; K A Foo; J Rodriguez
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Expanded gentamicin volume of distribution in patients with indicators of malnutrition.

Authors:  B J Zarowitz; A M Pilla; J Popovich
Journal:  Clin Pharm       Date:  1990-01

3.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group.

Authors:  S R Gitterman; G L Drusano; M J Egorin; H C Standiford
Journal:  Clin Pharmacol Ther       Date:  1990-08       Impact factor: 6.875

5.  Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine.

Authors:  A Mallet; F Mentré; J L Steimer; F Lokiec
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

6.  Alterations in aminoglycoside volume of distribution in patients below ideal body weight.

Authors:  M M Tointon; M L Job; T T Peltier; J E Murphy; E S Ward
Journal:  Clin Pharm       Date:  1987-02

7.  Steady-state pharmacokinetics of phenytoin from routinely collected patient data.

Authors:  T H Grasela; L B Sheiner; B Rambeck; H E Boenigk; A Dunlop; P W Mullen; J Wadsworth; A Richens; T Ishizaki; K Chiba
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

8.  Population pharmacokinetics of procainamide from routine clinical data.

Authors:  T H Grasela; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

9.  Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method.

Authors:  W F Dodge; R W Jelliffe; C J Richardson; R A McCleery; J A Hokanson; W R Snodgrass
Journal:  Clin Pharmacol Ther       Date:  1991-07       Impact factor: 6.875

10.  Pharmacokinetics of theophylline in protein-calorie malnutrition.

Authors:  D Jung
Journal:  Biopharm Drug Dispos       Date:  1985 Jul-Sep       Impact factor: 1.627

View more
  8 in total

1.  Limited-sampling strategies for anti-infective agents: systematic review.

Authors:  Denise A Sprague; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2009-09

2.  Gentamicin dosing for pediatric patients with congenital heart disease.

Authors:  Brady S Moffett; Sara J D Bork; Antonio R Mott
Journal:  Pediatr Cardiol       Date:  2010-06-12       Impact factor: 1.655

3.  Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy.

Authors:  J F Inciardi; K K Batra
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

4.  NM-Win: a personal computer-based Microsoft Windows front-end to NONMEM IV.

Authors:  J P Vielhaber; J S Barrett
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 5.  Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective.

Authors:  E Samara; R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

6.  Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.

Authors:  T M Gilman; S R Brunnemann; J L Segal
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

7.  Bayesian pharmacokinetics of gentamicin in a haemodialysis population.

Authors:  Lavern M Vercaigne; Robert E Ariano; James M Zacharias
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 8.  Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?

Authors:  Alexandre Duong; Chantale Simard; Yi Le Wang; David Williamson; Amélie Marsot
Journal:  Antibiotics (Basel)       Date:  2021-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.